News

Sartorius Stedim Biotech, a leading provider of solutions for the biopharmaceutical industry, has announced a new strategic partnership with Nanotein Technologies, a California-based…
Read More...

Arvinas, Inc., in partnership with Pfizer, announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for vepdegestrant, a novel oral…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered into a definitive agreement with Seikagaku Corporation to co-develop and exclusively market Gel-One, Seikagaku’s…
Read More...

CorMedix Inc. and Melinta Therapeutics LLC announced a definitive agreement for CorMedix to acquire Melinta. The selling shareholders will receive $300 million in total consideration at…
Read More...

Valneva SE announced that the U.S. Food and Drug Administration (FDA) has lifted its previously recommended pause on the use of the company’s Chikungunya vaccine, IXCHIQ, in individuals…
Read More...

Genmab A/S announced promising Phase 3 results from its EPCORE FL-1 clinical trial, which evaluated epcoritamab—a subcutaneous bispecific antibody—combined with rituximab and…
Read More...

Cingulate Inc., a biopharmaceutical company specializing in next-generation pharmaceutical products through its proprietary Precision Timed Release (PTR) technology, announced it has…
Read More...

Fresenius Kabi is expanding its biopharmaceutical portfolio through a new global licensing agreement with Polpharma Biologics S.A., securing exclusive rights to commercialize the…
Read More...

In a significant development for pediatric migraine care, Teva Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for AJOVY…
Read More...

Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso (dordaviprone) for the treatment of adult and pediatric…
Read More...

Astria Therapeutics, Inc. has entered into an exclusive licensing agreement with Kaken Pharmaceutical Co., Ltd., granting Kaken the rights to develop and commercialize navenibart in…
Read More...

Axplora, a global leader in API small molecule manufacturing, has announced a €6.5 million investment to expand production capacity at its Vizag site in India. This move aims to boost…
Read More...

SERB Pharmaceuticals, a global specialty pharma company focused on rare diseases and medical emergencies, announced it has entered a definitive agreement to acquire Y-mAbs Therapeutics,…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental biologics license application (sBLA) for Breyanzi (lisocabtagene…
Read More...

Agios Pharmaceuticals, Inc. announced that the Saudi Food and Drug Authority (SFDA) has approved PYRUKYND (mitapivat) for the treatment of adult patients with non-transfusion-dependent…
Read More...

Atombeat Inc., a leader in AI-driven drug discovery, and BioDuro, a global contract research, development, and manufacturing organization (CRDMO), have announced a strategic partnership…
Read More...

Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS, including its state-of-the-art J.POD biologics development and…
Read More...

Repligen Corporation has announced a strategic partnership with Novasign aimed at accelerating the digital transformation of bioprocessing. The collaboration will focus on integrating…
Read More...

Altasciences and VoxCell BioInnovation have announced a strategic collaboration aimed at transforming preclinical drug development by integrating advanced 3D bioprinted tissue models…
Read More...

Eli Lilly and Company has announced positive topline results from its landmark SURPASS-CVOT trial, a large-scale Phase 3 study comparing two widely used diabetes drugs—Mounjaro…
Read More...